PAK4 controls cell proliferation, survival, invasion, metastasis, the epithelial–mesenchymal transition (EMT), and drug resistance in vitro and in vivo (Fig. 3), thereby promoting overall cancer progression14,21,22,29,30. Here, PAK4 is linked to cancer.